Featured Research

from universities, journals, and other organizations

New framework for neglected tropical diseases could help world's poorest people

Date:
November 25, 2013
Source:
Sabin Vaccine Institute
Summary:
A new concept and policy framework urges G20 countries to lead on making greater investments in neglected tropical diseases in light of new era in global health and development.

A new concept and policy framework published in PLOS NTDs outlines concrete steps for the global development community as it works to synthesize health goals with economic, environmental and social priorities. The concept, "blue marble health," emphasizes the role of the Group of 20 (G20) nations in tackling neglected tropical diseases (NTDs) to expedite poverty reduction efforts.

"Blue marble health connects countries worldwide by recognizing that extreme poverty is a fundamental underlying factor for neglected tropical diseases (NTDs), regardless of where they occur," said the concept's author, professor Peter Hotez, MD PhD, president of the Sabin Vaccine Institute, director of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development and dean of the National School of Tropical Medicine at Baylor College of Medicine. "G20 countries have an exceptional opportunity to embrace NTD control as a cross-cutting strategy and achieve long-lasting, inclusive prosperity within their societies and lower-income countries."

While it is accepted that NTDs affect the world's poorest and most marginalized people living on less than $1.25 a day, the hidden burden of disease among impoverished people in emerging markets and wealthier nations has gone largely unnoticed.

Much of the disease burden within G20 countries falls on marginalized communities in Indonesia and the BRICS (Brazil, Russia, India, China, and South Africa), but there are also several NTDs found in Eastern and Southern Europe, and in the southern United States.

Blue marble health advises the G20 to lead on the following areas:

• Expanding the Portfolio: New information from the Global Burden of Disease Study 2010 highlights the urgency to expand global control and elimination programs to include leishmaniasis, dengue, and food-borne trematode infections.

• Research and Development (R&D): Existing medicines for the seven most common NTDs are safe, effective, and inexpensive. However, new tools and diagnostics will help us stay ahead of how current treatment needs evolve and enable us to address several NTDs for which there are no current options available. G20 countries have an important role to play in investing in R&D, including building up the local capacity of vaccine manufacturers in disease-endemic countries.

• Vaccine Diplomacy: Promoting scientific collaboration between institutions from countries regardless of their ideological perspectives can foster essential dialogue on these life-threatening diseases and lead to new, effective interventions.

• NTD Integration: Strong linkages exist between NTDs and nearly every major development priority. Efforts to control and eliminate should be incorporated into existing programs working to improve maternal and child health; water, sanitation and hygiene; hunger and nutrition; education; and combat HIV/AIDS, tuberculosis and malaria.

• Health of Girls and Women: This population is especially disproportionately affected -- indeed NTDs may be the most common afflictions of girls and women living in poverty.

• NCDs: NTDs contribute to a hidden but substantial proportion of the world's non-communicable diseases.

• Sustainable Development Goals (SDGs): Controlling NTDs will serve as a catalyst for the achievement of the Millennium Development Goals and a broad set of issues likely to be addressed in the new SDGs. It will be essential to incorporate NTDs into this framework.

"G20 countries are well-positioned to usher in a new era of enduring economic growth by making the cost-effective investment in people's health. Now is the time to leverage their power and resources to bring about the next wave of successes in NTD control and elimination," said Dr. Hotez.


Story Source:

The above story is based on materials provided by Sabin Vaccine Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Peter J. Hotez. NTDs V.2.0: “Blue Marble Health”—Neglected Tropical Disease Control and Elimination in a Shifting Health Policy Landscape. PLoS Neglected Tropical Diseases, 2013; 7 (11): e2570 DOI: 10.1371/journal.pntd.0002570

Cite This Page:

Sabin Vaccine Institute. "New framework for neglected tropical diseases could help world's poorest people." ScienceDaily. ScienceDaily, 25 November 2013. <www.sciencedaily.com/releases/2013/11/131125101009.htm>.
Sabin Vaccine Institute. (2013, November 25). New framework for neglected tropical diseases could help world's poorest people. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2013/11/131125101009.htm
Sabin Vaccine Institute. "New framework for neglected tropical diseases could help world's poorest people." ScienceDaily. www.sciencedaily.com/releases/2013/11/131125101009.htm (accessed October 21, 2014).

Share This



More Science & Society News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
Robots to Fly Planes Where Humans Can't

Robots to Fly Planes Where Humans Can't

Reuters - Innovations Video Online (Oct. 21, 2014) Researchers in South Korea are developing a robotic pilot that could potentially replace humans in the cockpit. Unlike drones and autopilot programs which are configured for specific aircraft, the robots' humanoid design will allow it to fly any type of plane with no additional sensors. Ben Gruber reports. Video provided by Reuters
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
'Cadaver Dog' Sniffs out Human Remains

'Cadaver Dog' Sniffs out Human Remains

AP (Oct. 21, 2014) Where's a body buried? Buster's nose can often tell you. He's a cadaver dog, specially trained to find human remains and increasingly being used by law enforcement and accepted in courts. These dogs are helping solve even decades-old mysteries. (Oct. 21) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Science & Society

Business & Industry

Education & Learning

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins